COLUMN GROUP L P 13D and 13G filings for NGM Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-05 10:55 am Sale |
2024-04-05 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 1,000 100.000% |
-22,078,509 (-100.00%) |
Filing |
| 2024-02-26 5:16 pm Unchanged |
2024-02-25 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 22,079,509 26.700% |
0 (Unchanged) |
Filing |
| 2023-12-29 4:05 pm Purchase |
2023-12-28 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 22,079,509 26.700% |
1,094,533 (+5.22%) |
Filing |
| 2022-06-10 4:14 pm Purchase |
2022-06-01 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 20,984,976 26.500% |
1,951,343 (+10.25%) |
Filing |
| 2022-02-03 5:23 pm Purchase |
2022-01-24 | 13D | NGM Biopharmaceuticals, Inc. NGM |
COLUMN GROUP L P | 19,033,633 24.500% |
1,378,422 (+7.81%) |
Filing |